Xcout IntelParabilis Medicines, Inc. competitors & alternatives
The 12 closest competitors and alternatives to Parabilis Medicines, Inc. among pharmaceuticals companies — ranked by similarity to what Parabilis Medicines, Inc. actually does, not by market-cap band.
Subscribe to see Parabilis Medicines, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Parabilis Medicines, Inc.
Fog Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane in 2015 and is headquartered in Cambridge, MA.
Parabilis Medicines, Inc. at a glance
Parabilis Medicines, Inc. is a pharmaceuticals company headquartered in Cambridge, United States. It is publicly listed (PBLS) with a market capitalisation of $3.2B. Xcout tracks 20 named people at Parabilis Medicines, Inc., including Mathai Mammen (CEO, President, Treasurer & Chairman). Xcout recorded 31 job postings from Parabilis Medicines, Inc. in the last 90 days, naming tools such as Claude Code, Okta.
Parabilis Medicines, Inc. leadership
- Mathai MammenCEO, President, Treasurer & Chairman
- Thomas Rodolpho KotarakosChief Financial Officer
- Mohammed Fawzi BenzaghouChief Medical Officer
- Huei-inChief Business & Strategy Officer
- Kristen StantsChief People Officer
- Rohin MhatreChief Technical Operations Officer
14 more named people on record for Parabilis Medicines, Inc., with roles, board committees and tenure — see the full roster →
Hiring at Parabilis Medicines, Inc.
Xcout recorded 31 job postings from Parabilis Medicines, Inc. in the last 90 days, from a hiring record Xcout has kept since June 2026.
Tools named in Parabilis Medicines, Inc.'s job postings
The weekly hiring trend, the roles and locations behind it — see Parabilis Medicines, Inc.'s hiring signals →
Recent Parabilis Medicines, Inc. news
- IPOParabilis Medicines, Inc. IPO on NASDAQ
- IPOIPO registration (S-1)
- IPOIPO registration (S-1)
- IPOIPO registration (S-1)
6 corporate events on record, with sources — see the full timeline →
Top 12 Parabilis Medicines, Inc. competitors
Ranked by semantic similarity — how close each company is to Parabilis Medicines, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar pharmaceuticals company
Danqing Pharmaceuticals is a pharmaceutical company headquartered in Beijing with a U.S. subsidiary in Boston. The company focuses on first-in-class drug discovery and development in oncology, targeting therapeutic areas such as breast, gynecological, and gastrointestinal cancers.
Similar pharmaceuticals company
Cao Pharmaceuticals Inc. develops anti-cancer drugs utilizing natural anti-cancer compounds. The company focuses on research, product pipelines, and developing lead drug candidates for cancer treatment.
Similar pharmaceuticals company
Shanghai CureGene Pharmaceutical Co., Ltd. is a biopharmaceutical company founded in Zhangjiang, Shanghai, in 2018. It specializes in developing state-of-the-art medications and has built a globally leading targeted prodrug platform.
Similar pharmaceuticals company
Arisaph Pharmaceuticals Inc. is a Boston, Massachusetts-based biopharmaceutical company that utilizes drug discovery platforms to develop novel therapies for cancer, cardiovascular disease, and diabetes. The company's pipeline includes small molecule inhibitors and differentiated medicines aimed at cardiometabolic diseases and oncology.
Similar pharmaceuticals company
Novilla Pharmaceuticals is a biotechnology company headquartered in Cambridge, Massachusetts, developing a novel class of localized medicines designed by AI to treat pain. The firm focuses on targeted therapeutics that function only where needed within the body. It operates as a privately held startup with a small scientific team.
Biotech
Foghorn Therapeutics is a biopharmaceutical company headquartered in Watertown, Massachusetts. The company is pioneering a new class of medicines that treat serious diseases by leveraging insights into the chromatin regulatory system.
Biotechnology
BIND Therapeutics, Inc. is a clinical-stage nanomedicine company headquartered in Cambridge, Massachusetts. The company specializes in developing targeted and programmable therapeutics using its proprietary platform to treat various diseases.
Biotechnology
Vibrant Therapeutics is a clinical-stage biotechnology company headquartered in Cambridge, Massachusetts, with operations in China. Founded in July 2019, the firm focuses on revolutionizing protein drug discovery and developing next-generation prodrugs with precise targeting.
Biotech
Expedition Medicines, Inc. is a biotechnology company founded in 2022 and headquartered in Cambridge, Massachusetts, focused on generatively designing novel drugs targeting specific proteins.
Healthcare
GRO Biosciences Inc. is an emerging biotechnology company headquartered in Cambridge, Massachusetts. The company leverages groundbreaking science to expand the amino acid alphabet and deliver on the promise of advanced protein therapeutics.
Biotechnology
BridGene Biosciences, Inc. is a biotechnology company headquartered in San Jose, California, pioneering next-generation chemoproteomics through its IMTAC platform. The company is focused on discovering and developing innovative small molecule drugs for high-value targets.
Biotechnology
Dewpoint Therapeutics is an integrated drug discovery platform company headquartered in Boston, Massachusetts. The firm leverages advanced biotechnology to translate condensate biology into novel medicines for various therapeutic areas.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Parabilis Medicines, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Parabilis Medicines, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →